SEARCH

SEARCH BY CITATION

References

  • Bell, D. M., Leung, K. K., Wheatley, S. C. et al. 1997. SOX9 directly regulates the type-II collagen gene. Nat. Genet. 16, 174178.
  • Bi, W., Deng, J. M., Zhang, Z., Behringer, R. R., De Crombrugghe, B. 1999. Sox9 is required for cartilage formation. Nat. Genet. 22, 8589.
  • Bouwmeester, T., Kim, S. H., Sasai, Y., Lu, B., De Robertis, E. M. 1996. Cerberus is a head-inducing secreted factor expressed in the anterior endoderm of Spemann’s organizer. Nature 382, 595601.
  • Brunet, L., McMahon, J., McMahon, A., Harland, R. 1998. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280, 14551457.
  • Brysch, W. & Schlingensiepen, K. H. 1994. Design and application of antisense oligonucleotides in cell culture, in vivo, and as therapeutic agents. Cell. Mol. Neurobiol. 14, 557568.
  • Cameron, F. J., Hageman, R. M., Cooke-Yarborough, C. et al. 1996. A novel germ line mutation in SOX9 causes familial campomelic dysplasia and sex reversal. Hum. Mol. Genet. 5, 16251630.
  • Cheah, K. S., Lau, E. T., Au, P. K., Tam, P. P. 1991. Expression of the mouse alpha 1 (II) collagen gene is not restricted to cartilage during development. Development 111, 945953.
  • Duprez, D., Bell, E. J. D., Richardson, M. K. et al. 1996. Overexpression of Bmp-2 and Bmp-4 Alters the Size and Shape of Developing Skeletal Elements in the Chick Limb. Mech. Dev. 57, 145157.
  • Fainsod, A., Deissler, K., Yelin, R. et al. 1997. The dorsalizing and neural inducing gene follistatin is an antagonist of BMP-4. Mech. Dev. 63, 3950.
  • Healy, C., Uwanogho, D., Sharpe, P. T. 1999. Regulation and role of Sox9 in cartilage formation. Dev. Dyn. 215, 6978.
  • Hogan, B. L. 1996. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10, 15801594.
  • Katagiri, T., Yamaguchi, A., Ikeda, T. et al. 1990. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem. Biophys. Res. Commun. 172, 295299.
  • Kielty, C. M., Kwan, A. P., Holmes, D. F., Schor, S. L., Grant, M. E. 1985. Type X collagen, a product of hypertrophic chondrocytes. Biochem. J. 227, 545554.
  • Kosher, R. A., Kulyk, W. M., Gay, S. W. 1986. Collagen gene expression during limb cartilage differentiation. J. Cell Biol. 102, 11511156.
  • Kravis, D. & Upholt, W. B. 1985. Quantitation of type II procollagen mRNA levels during chicken limb cartilage. Dev. Biol. 108, 164172.
  • Lamb, T. M., Knecht, A. K., Smith, W. C. et al. 1993. Neural induction by the secreted polypeptide Noggin. Science 262, 713718.
  • Lyons, K. M., Hogan, B. L. M., Robertson, E. J. 1995. Colocalization of BMP7 and BMP2 RNAs suggests that these factors cooperatively mediate tissue interactions during murine development. Mech. Dev. 50, 7183.
  • Lyons, K. M., Pelton, R. W., Hogan, B. L. 1990. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2a (BMP-2a). Development 109, 833844.
  • Macias, D., Ganan, Y., Sampath, T. K., Piedra, M. E., Ros, M. A., Hurie, J. M. 1997. Role of bmp-2 and op-1 (bmp-7) in programmed cell death and skeletogenesis during chick limb development. Development 124, 11091117.
  • Marcelle, C., Stark, M., Bronner-Fraser, M. 1997. Coordinate actions of BMPs, Wnts, Shh and Noggin mediate patterning of the dorsal somite. Development 124, 39553963.
  • Von Der Mark, K., Von Der Mark, H., Gay, S. 1976. Study of differential collagen synthesis during development of the chick embryo by immunofluorescence. Dev. Biol. 53, 153170.
  • McMahon, J. A., Takada, S., Zimmerman, L. B., Fan, C. M., Harland, R. M., McMahon, A. P. 1998. Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev. 12, 14381452.
  • Metsaranta, M., Toman, D., De Crombrugghe, B., Vuorio, E. 1991. Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. Biochim. Biophys. Acta 1089, 241243.
  • Page, K., Stevens, A., Lowe, J., Bancroft, J. 1996. Bone. In Theory and Practice of Histological Techniques (Eds J. D. Bancroft & A. Stevens), pp. 332–334. Churchill Livingstone, New York.
  • Pevny, L. H. & Lovell-Badge, R. 1997. Sox genes find their feet. Curr. Opin. Genet. Dev. 7, 338344.
  • Poole, A. R. 1991. The Growth Plate: Cellular Physiology, Cartilage Assembly and Mineralization. In Cartilage: Molecular Aspects (Eds B. K. Hall & S. A. Newman), pp. 179–211. CRC Press, Boca Raton, USA.
  • Prior, H. M. & Walter, M. A. 1996. Sox genes: architects of development. Mol. Med. 2, 405412.
  • Re’em Kalma, Y., Lamb, T., Frank, D. 1995. Competition between noggin and bone morphogenetic protein 4 activities may regulate dorsalization during Xenopus development. PNAS 92, 12 14112 145.
  • Reddi, A. H. 1997. Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens. Cytokine Growth Factor Rev. 8, 1120.
  • Sasai, Y., Lu, B., Steinbeisser, H., Geissert, D., Gont, L. K., De Robertis, E. M. 1994. Xenopus chordin: a novel dorsalizing factor activated by organizer-specific homeobox genes. Cell 79, 779790.
  • Savontaus, M., Metsäranta, M., Vuorio, E. 1996. Retarded skeletal development in transgenic mice with a type II collagen mutation. Am. J. Pathol. 149, 21692182.
  • Stoykova, A. & Gruss, P. 1994. Roles of Pax genes in developing and adult brain as suggested by expression patterns. J. Neurosci. 14, 13951412.
  • Sudbeck, P., Schmitz, M. L., Baeuerle, P. A., Scherer, G. 1996. Sex reversal by loss of the C-terminal transactivation domain of human SOX9. Nat. Genet. 13, 230232.
  • Tickle, C. & Eichele, G. 1994. Vertebrate Limb Development. Annu. Rev. Cell Biol. 10, 121152.
  • Tonegawa, A. & Takahashi, Y. 1998. Somitogenesis controlled by noggin. Dev. Biol. 202, 172182.DOI: 10.1006/dbio.1998.8895
  • Wagner, T., Wirth, J., Meyer, J. et al. 1994. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79, 11111120.
  • Wang, E. A., Israel, D. I., Kelly, S., Luxenberg, D. P. 1993. Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells. Growth Factors 9, 5771.
  • Wang, E. A., Rosen, V., D’Alessandro, J. S. et al. 1990. Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl Acad. Sci. USA 87, 22202224.
  • Wilkinson, D. G. 1992. In Situ Hybridization: A Practical Approach. IRC Press at Oxford University Press, Oxford.
  • Wotton, D., Lake, R. A., Farr, C. J., Owen, M. J. 1995. The high mobility group transcription factor, SOX4, transactivates the human CD2 enhancer. J. Biol. Chem. 270, 75157522.
  • Wozney, J. M. 1989. Bone morphogenetic proteins. Prog. Growth Factor Res. 1, 267280.
  • Wozney, J. M. 1998. The bone morphogenetic protein family – multifunctional cellular regulators in the embryo and adult. European J. Oral Sci. 106, 160166.
  • Wright, E., Hargrave, M. R., Christiansen, J. et al. 1995. The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat. Genet. 9, 1520.
  • Zehentner, B. K., Dony, C., Burtscher, H. 1999. The transcription factor Sox9 is involved in BMP-2 signaling. J. Bone Mineral Res. 14, 17341741.
  • Zimmerman, L. B., De Jesus-Escobar, J. M., Harland, R. M. 1996. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86, 599606.